
Trazim-TM 1.125gm Injection
Marketer
Aster Pharma
Salt Composition
Ceftazidime (1gm) + Tazobactum (125mg)
Overview Trazim-TM 1.125gm Injection
Combiflox-1.125gm Injection, a multi-component medication, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, thereby curbing infection spread. Administration must be solely under a doctor's guidance. Consistent adherence to the prescribed schedule is crucial; complete the full course, even with symptom improvement, as premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate medical attention. Seek immediate medical assistance for allergic reactions (e.g., rash, itching, swelling, respiratory distress). Inform your physician of all current medications before commencing treatment. Pregnant or lactating individuals should consult their physician prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and sufficient hydration are recommended for optimal recovery. Monitoring may involve periodic lab tests to assess treatment effectiveness.
Primary Ingredients of Trazim-TM 1.125gm Injection
No information provided. A rephrased version cannot be created.
Uses of Trazim-TM 1.125gm Injection
Infections caused by bacteria
Major Benefits of Trazim-TM 1.125gm Injection:
The medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Trazim-TM 1.125gm Injection:
- Nausea
- Vomiting
- Diarrhea
- Stomach pain
- Increased liver enzymes
- Allergic reaction
How to use Trazim-TM 1.125gm Injection:
The medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Trazim-TM 1.125gm Injection works:
Trazim-TM 1.125gm Injection unites Ceftazidime, a bacterial cell wall synthesis inhibitor antibiotic, with Tazobactam, a beta-lactamase inhibitor. This synergistic combination combats bacterial infection by disrupting bacterial defenses and boosting Ceftazidime's efficacy.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Trazim-TM 1.125gm Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Trazim-TM, 1.125gm, is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, clinical data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable formulation of Trazim-TM, 1.125gm, presents no known breastfeeding contraindications. Research in human subjects indicates negligible transfer of the medication into breast milk, posing no identified risk to the infant.
DrivingUNSAFE
Administering Trazim-TM 1.125gm Injection might reduce awareness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if such effects are experienced.
KidneyCAUTION
For individuals with impaired kidney function, Trazim-TM 1.125gm Injection requires careful administration. Dosage modification of Trazim-TM 1.125gm Injection might be necessary; physician consultation is advised.
LiverCAUTION
For individuals with significant hepatic impairment, administration of Trazim-TM 1.125gm Injection requires careful monitoring. A modified dosage of Trazim-TM 1.125gm Injection may be necessary. Physician consultation is advised.
What if you forget to take Trazim-TM 1.125gm Injection :
Omitting a scheduled dose of Trazim-TM 1.125gm Injection warrants immediate physician consultation.
Facts to Know About Trazim-TM 1.125gm Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
